Limited submission: Each eligible institution may submit up to a combined total
of four applications (one in Cancer Data Science, one in Cancer Control
Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer
Research) to any companion NOFO or any combination of companion NOFOs
(PAR-23-286, PAR-23-287, and/or PAR-23-288).

The purpose of the NCI Pathway to Independence Award for
Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and
maintain a strong cohort of new and talented, NCI-supported, independent
investigators. This program is designed for postdoctoral fellows with research
and/or clinical doctoral degrees who do not require an extended period of
mentored research training beyond their doctoral degrees. The objective of this
award is to facilitate a timely transition of these fellows from their mentored,
postdoctoral research positions to independent tenure-track (or equivalent)
faculty positions. The program will provide independent NCI research support
during this transition to help awardees launch competitive, independent
research careers. Researchers in the scientific areas of cancer control, cancer
prevention and cancer data sciences are especially encouraged to work with
their institutions to apply.



This Notice of Funding Opportunity (NOFO) is designed specifically for
candidates proposing to serve as the lead investigator of an independent
clinical trial, a clinical trial feasibility study, or a separate ancillary
clinical trial, as part of their research and career development. Those not
planning an independent clinical trial, or proposing to gain research
experience in a clinical trial led by another investigator, must apply to
companion NOFO (PAR-23-286).